Cellebration Life Sciences ^Company

Cellebration Life Sciences offers and administers stem-cell-based therapies which are highly specialized to treat specific degenerative conditions and directly target the area of concern in rejuvenation therapies. Cellebration Life Sciences currently has underway an FDA Clinical Trial application to develop a curative treatment for Type 2 Diabetes. The company is also conducting further research to advance efforts to find permanent curative treatments for arthritis and other autoimmune diseases.